Duluth (DLTH) Q1 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2027 earnings summary
9 Jun, 2026Executive summary
Net sales for Q1 2026 declined 4% year-over-year to $98.6 million, primarily due to lower direct-to-consumer sales, while retail store sales grew 3.3% on higher average order values and new store openings.
Net loss narrowed to $10.0 million from $15.3 million year-over-year, reflecting improved gross margin and reduced SG&A expenses.
Adjusted EBITDA improved to $2.6 million from negative $3.8 million in the prior year, a $6.4 million increase.
Gross margin expanded by 540 basis points to 57.4% due to reduced promotions, improved product cost structure, and better sourcing.
Inventory reduced by 24.8% year-over-year, supporting stronger liquidity and improved customer quality.
Financial highlights
Gross profit increased 6.1% year-over-year to $56.6 million, with gross margin rising to 57.4% from 52.0%.
SG&A expenses decreased by $3.4 million (5.2%) to $61.8 million, leveraging by 70 basis points.
Adjusted EPS was ($0.20), excluding $2.7 million in impairment and $1.4 million in restructuring expenses.
Net cash used in operating activities was $13.4 million, a significant improvement from $56.5 million in Q1 2025.
Free cash flow improved by $42.6 million compared to the same period last year.
Outlook and guidance
Affirmed full-year fiscal 2026 net sales guidance of $540–$560 million, a 1%–5% decline year-over-year due to continued promotional reset.
Adjusted EBITDA guidance raised to $28–$32 million from $26–$30 million.
Capital expenditure guidance maintained at $12 million (2.2% of sales).
First half sales expected to decrease 6%–10%, stabilizing in the second half within a range of -2% to +2%.
Management expects continued macroeconomic headwinds, including inflation and recessionary concerns.
Latest events from Duluth
- Annual meeting to elect directors, approve pay, and ratify auditors, with online voting options.DLTH
Proxy filing21 Apr 2026 - Director elections, executive pay, and auditor ratification headline the annual meeting agenda.DLTH
Proxy filing21 Apr 2026 - Gross margin expanded, net loss narrowed, and guidance projects stable sales with EBITDA growth.DLTH
Q4 202619 Mar 2026 - Q2 net sales up 1.8%, gross margin expanded, and FY2024 outlook reaffirmed.DLTH
Q2 202522 Jan 2026 - Q3 net sales fell 8.1% to $127.1M, gross margin rose to 52.3%, net loss reached $28.5M.DLTH
Q3 202511 Jan 2026 - Sales fell 3% to $626.6M; 2025 outlook targets EBITDA growth and no debt.DLTH
Q4 202526 Dec 2025 - Profitability and margins improved with higher gross margin and lower costs, despite lower sales.DLTH
Q3 202619 Dec 2025 - Board elections, CEO transition, and auditor ratification headline the annual meeting agenda.DLTH
Proxy Filing1 Dec 2025 - Definitive additional proxy materials filed for shareholder voting, no fee required.DLTH
Proxy Filing1 Dec 2025